Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
iktos logo — Artificial intelligence for new drug design

iktos

Artificial intelligence for new drug design

Founded 2016 France France 85 employees Series A Total: $18.90M AI, Biotechnology +2

General Information

Company Name iktos
Founded Year 2016
Location France France +3
Founders / Decision Makers
Team member
Employees 85
Industries AI, Biotechnology, Health Care +1
Funding Stage Series A
Social

Get notified when iktos moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About iktos

Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry.

The company's proprietary generative AI solutions, offered through the Makya™ and Spaya™ platforms, enhance small molecule drug discovery, boosting accuracy and efficiency. Through its strategic SaaS model, Iktos collaborates with pharma giants to expedite R&D processes.

The company's notable milestones include a €15.5M Series A financing round in March 2023 and the July 2024 acquisition of Synsight, enhancing its capabilities in targeting PPI and RPI. The recent $2.50M grant from the European Innovation Council reinforces investor confidence in its innovative approach.

Taxonomy: Drug Design, Medicinal Chemistry, Generative AI, Chemoinformatics, Robotics Automation, SaaS Software, Molecular Modeling, Oncology, Retrosynthesis, Protein-Protein Interactions, RNA-Protein Interactions, Synthesis Automation, Pharmaceutical R&D, Lead Optimization

Services & Products

Generative AI Platform (Makya)
AI-Driven Retrosynthesis (Spaya)
Automated Drug Development Pipeline
Autonomous Lab Robotics

Target Customers

Pharmaceutical Companies Biotech Firms Academic Institutions Medicinal and Computational Chemists Drug Discovery Teams

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Oct 2024
Series A •••••• 3
Investor Investor Investor
01 Mar 2023
Debt Financing •••••• 1
Investor
01 Jan 2021
Seed •••••• - 01 Jan 2019
Support Program •••••• 1
Investor
01 Feb 2018

View All 7 Funding Rounds

Latest News

View All
AWS names 12 European AI startups mapping oceans, diagnosing leukaemia, and predicting airstrikes — Thenextweb
AWS names 12 European AI startups mapping oceans, diagnosing leukaemia, and predicting airstrikes
Thenextweb Mar 18, 2026

iktos Alternatives & Competitors

View All Alternatives
iktos vs
Terray Therapeutics
Terray Therapeutics United States

Everything small molecule drug discovery should be.

Series B
142 employees
AI, Biopharma
Compare iktos vs Terray Therapeutics
iktos vs
CrystalsFirst
CrystalsFirst Germany

Turning Insights Into Medicines

Non Equity Assistance
18 employees
AI, Biotechnology
Compare iktos vs CrystalsFirst
iktos vs
Venenum BioDesign, LLC
Venenum BioDesign, LLC United States

DISCOVERY IS OUR MISSION

27 employees
Biotechnology
Also compare with: iktos vs Genosco Genosco View all alternatives

FAQ About iktos

Artificial intelligence for new drug design
iktos was founded in 2016.
iktos is headquartered in France.
iktos operates in the following industries: AI, Biotechnology, Health Care, Pharmaceutical.
iktos has approximately 85 employees.
iktos has completed 7 funding rounds, raising a total of $18.90M. The latest funding stage is Series A.
iktos offers: Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics.
Top alternatives and competitors to iktos include Terray Therapeutics, CrystalsFirst, Venenum BioDesign, LLC, Expedition Medicines, Genosco. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iktos and Terray Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors iktos and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy